Part of funding portal member: truCrowd, Inc.
Mobile Menu

Shaman Productions

Patent Pending CBD/CBG Infused Proprietary Formulations Targeting Symptoms Including, But Not Limited To; Aging, Herpes Simplex, Zoster, And Diabetes

Minimum target reached
Closed on 03/17/22


amount committed 

$10k - $1070k

funding goal 

Regulation CF

exemption used 


pre money valuation 


min investment 



Security Type
Valuation Cap: $5,000,000
Discount: 20%

Who are we

Shaman Productions is the owner of the revolutionary new Abetyu´ Naturals Product Line. Cofounded by a Clinical Scientist and a Medical Doctor, Abeytu' Naturals is using safe and effective applications of Cannabidiol Isolate plus a proprietary blend of micronutrients to assist in the management of targeted chronic medical ailments.  Shaman Productions accomplishes this by targeting Immune receptors to assist in achieving functional vs dysfunctional Immune Responses as well as addressing the four types of aging, (Liver/ Kidney/ Immune/ Metabolic). The company has four pending patent applications using their feature formulation, pertaining to Type 1 & 2 Diabetes, HSV1 & 2, Fungus and Microbials, and other Antiviral Applications. This exciting investment opportunity will help us bridge the gap between modern medicine and effective natural remedies, and allow our investors to be part of a worldwide movement in reducing the use of prescription medications and their side effects while offering over-the-counter alternatives without major side effects.  We believe that Plants Do It better, and we can prove it.


Consumer awareness regarding health issues is fueling a market that will continue to grow rapidly over the next 7-10 years. Naturopathic solutions related to increasing immune system performance and regulation, weight management, reducing anxiety levels, offering efficient fat and glucose metabolism, reducing gastrointestinal diseases, reducing pain, and increasing life expectancy are becoming mainstream. The elevated cost for prescriptions and their side effects, health insurance, and lack of preventative solutions, in general, are expected to propel the demand for Shaman products. There are currently outdated, unreliable, immunosuppressive, and ineffective OTC (over-the-counter) treatments. We plan to remove the accessibility, affordability, and economic roadblocks while providing consumers with working solutions.

Customers and patients need OTC solutions that have a lasting impact on personal health.



Shaman Naturals is our patent-holding company; licensing the full use of currently four pending patents through Shaman Productions. We have an IP strategy protecting all of our Intellectual Property, ensuring access and alternatives are available to consumers without suppression.  Shaman Productions wants to provide a natural cellular approach that is more accessible and effective for health and wellness as we focus on prevention and treatment through micronutrient cellular repair and conductivity.

Shaman Productions specifically uses the natural endocannabinoid system in conjunction with the immune cells and well-known natural healing agents. Not only do we believe in our products, but we believe the heart behind their development will draw you to become members of our movement, or better yet investors to be part of our worldwide implementation of the reduction of synthetic alternatives. We want you to be part of our solutions. Abeytu ́ is For You too.


In daily practice, we encounter a lack of access to patient medical and advocate resources. Frustration with antiquated processes and disconnections between traditional pharmaceutical intervention, naturopathic treatments, and patients’ needs; inspired the Abeytu ́ Naturals product line. No longer will limited access to financial resources, insurance, prescriptions, and healthcare; prevent people from relief over chronic conditions. Streamlining this system through OTC/online natural plant-based targeted solutions could be the bridge we have been searching for. We intend to address pain while taking action against the causative agent. We Strongly Believe; MANUFACTURED DRUGS DON'T HAVE SPIRITUAL ABILITIES, AND PLANTS JUST DO IT BETTER.




Shaman Productions cofounders have managed to launch 7 products in just 12 short months from their personal financial reservoirs, demonstrating commitment, risk, and understanding of the line's potential impact on global health. A startup company with gross sales of $111,000 in 12 months, during a global pandemic is profound. The Abetyu' Naturals Product Line has been displayed at just 3 tradeshows thus far in 2021, and has received that "wow" reaction from both consumers and competitors.  The daily introduction to new consumers and strategic partners always leads to, "you guys are the ONLY ones doing this in your space", so we know we are on to something unique and proven. Shaman Productions should be successful in this space as we are the only CBD/CBG infused company with 4 pending patents and 3 internationally registered trademarks.  The company is incorporated in the United States territory of Puerto Rico to take advantage of the low business tax structure and future R & D and manufacturing credits.  Shaman has placed a great deal of emphasis on its foundation, having spent a great deal of funds in protecting IP and development of branding.  The company received Best In Show for packaging/branding at its first tradeshow Spring of 2021, and has already been recognized by Shark Discoveries Teams who will be marketing for the Abeytu' Naturals Product Line 4th qtr 2021.  The Abetyu' Naturals Line was also selected to compete in Las Vegas in the CBD Beauty category Aug 2021, in front of retailers from 7 countries.  Their achievements in the anti aging category have already been recognized and only 18 companies from all over the world are allowed this privelege of presentation this summer in Las Vegas.  The company's President is a successful communicator and scientist with an MBA, having testified in front of State Senate Legislations and given expert in -service seminars. She continues to receive invitations to provide education about natural healing from different media outlets around the country which will provide additional exposure and interest in Shaman. The company's Vice President is a medical expert in recognizing and diagnosing pathology and has an advanced understanding of body systems.  This cofounder duo continues to impress consumers and vendor partners with their drive and success in finding answers to many common health related problems.


The Shaman Productions ultimate goal of providing affordable access to safe and effective pharmaceutical alternatives in their own brick and mortar wellness centers complete with natural products, chemical free hemp based clothing, and alternative therapy healing rooms is just one crowdfunding campaign away from reality. Plants Do It Better will be on the voices and minds of consumers all over the world with the help of a successful campaign.


• Auto Immune Prevalence USA > 50,000,000 individual

• HSV1 3.7 Billion individuals infected

• HSV2 482 Million individuals infected

• HZoster (Shingles) 1 Million individuals annually and rising

• Obesity/Glucose dysregulation 1.9 Billion individuals affected

• Fungal 300 Million individuals affected

• Acne 682 Million individuals affected

• Anti-Aging $60.26 Billion markets projected by 2026

• Cannabidiol Industry $967 Million in 2020. Projected to $5.3 Billion by 2025 with a CAGR of 40.4%


Shaman Productions is in a niche of its own in the cannabinoid industry; having applications to target specific ailments and their causes as opposed to generalized "pain" relief. The company is uniquely qualified and successful in supporting the body's immune system to express functional vs dysfunctional responses to stimuli. Competitors include but are not limited to:

  • Any other Cannabinoid Company with historical presence and better financial grounding.
  • Pharmaceutical Companies; specifically those producing Acyclovir and Valtrex for demonstration purposes.
  • Traditional Medicine/Physicians are reluctant to use or prohibited from using natural remedies.

Shaman Productions will attempt to use its crowdfunding offering to secure a more stable financial foundation so it can improve marketing and recognition. This will also help launch specific scientific studies of its formulation efficacies, broaden the applications for the signature formulation, protect its natural remedies from the competition, and pay for increased legal protections. Shaman Productions will continue to educate practitioners on the clinical benefits of its formulations by increasing its footprint in functional and holistic healing offices. Building this alliance will help overcome the competition and legitimize the Abeytu' Naturals Product Line as a clinical force. 


Shaman Productions began manufacturing in June 2020 during the global economic shutdown and pandemic. Even though the company's resources and customer base were limited, they still managed over $53,000 in gross sales through December 31, 2020 with only two product SKU's. Thus far in 2021, also during global economic distress, Shaman Productions has gross sales of over $58,000, having launched four topical creams applicable to current patent-pending medicinal applications. Broader multi-functional marketing outreach, in-person eduction at tradeshows, increasing brand awareness and retail footprint in high-end hotels/spas/functional and naturopath clinical offices, international presence in both open and closed markets, a future chemical-free hemp clothing line to compliment our brand and natural products, as well as continued product development and IP protection will allow Shaman Productions to be a regional and global force and influencer.  



Maria Crisler CLS(NCA)MBA/HCM (CEO/President)

mariaOver 20 years of Clinical Experience in the multidiscipline of medicine and pathology. Former owner/operator full-service radiology center, OBgyn, Family Practice, Laboratory/Drug Analysis Clinics, Medical Aesthetics Clinics.










Emma DiPonio MD (Chief Medical Officer/Vice President)

EmmaOver 20 years of experience as a Diagnostic Radiologist Generalist with a specialty in venous disease treatments.  Former owner/operator venous disease treatment clinic and medical aesthetics clinic.










Mark Schleiger  MS/BS (Chief Operating Officer) 

MarkWith over 25 years of operations and executive national/international experience.  Mark has led teams both foreign and domestic for fortune 500 companies.











Terri Bos  (Chief Marketing Officer)


Over 25 years of digital and traditional marketing experience. Multiple strategic partners for manufacturing, sourcing, and distribution. 


Shaman Productions Executive Team has demonstrated commitment and constructed a solid business foundation to continue building upon.  The company is raising $1,070,000.00 that will go toward the following:

  • Crowdfunding Intermediary Fees of 8%
  • Campaign Marketing Expenses & Related Outreach 10%
  • Working Capital Sales and Product Marketing 35%
  • Product Development 47% 
  • This is not an exhaustive list but provides guidance on the company's weighted implementation of growth operations.




Unfortunately, this securities offering is closed. For questions, please email Thanks!


Offering Statement Download

Other Disclosures

Read the Form C filed with the SEC for other important disclosures, like financial statements, Directors, Officers, shareholders with more than 20% of voting rights, and more.
Use of Proceeds
The allocation of the use of proceeds among the categories of anticipated expenditures represents management’s best estimates based on the current status of the Company’s proposed operations, plans, investment objectives, capital requirements, and financial conditions. Future events, including changes in economic or competitive conditions of our business plan or the completion of less than the total Offering, may cause the Company to modify the above-described allocation of proceeds. The Company’s use of proceeds may vary significantly in the event any of the Company’s assumptions prove inaccurate. We will retain broad discretion in the allocation of the net proceeds from this Offering, reserve the right to change the allocation of net proceeds from the Offering as unanticipated events or opportunities arise and could utilize the proceeds in ways that do not necessarily improve our results of operations or enhance the value of our Common Stock. Additionally, the Company may from time to time need to raise more capital to address future needs that we may not have anticipated as of the date of this Offering Circular.
Special Note Regarding Forward-Looking Statements
This offering contains forward-looking statements within the meaning of the federal securities laws. We caution investors that any forward-looking statements presented in this offering, or which management may make orally or in writing from time to time, are based on the Company’s beliefs and assumptions made by, and information currently available to, the Company. When used, the words “anticipate,” “believe,” “expect,” “intend,” “may,” “might,” “plan,” “estimate,” “project,” “should,” “will,” “would,” “result” and similar expressions, which do not relate solely to historical matters, are intended to identify forward-looking statements. Such statements are subject to risks, uncertainties and assumptions and are not guarantees of future performance, which may be affected by known and unknown risks, trends, uncertainties and factors that are beyond the Company’s control. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated, estimated or projected. While forward-looking statements reflect the Company’s good faith belief when made, they are not guarantees of future performance. The Company expressly disclaims any responsibility to update forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Moreover, we operate in a very competitive and rapidly changing environment, and new risks emerge from time to time. It is not possible to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements we may make. In light of these risks, uncertainties and assumptions, the forward-looking events and circumstances discussed in this offering may not occur, and actual results could differ materially and adversely from those anticipated or implied in the forward-looking statements. We undertake no obligation to revise or publically release the results of any revision to these forward-looking statements, except as required by law. Given these risks and uncertainties, prospective investors are cautioned not to place undue reliance on such forward-looking statements.

Back to top